Extended spectrum beta-lactamases in Eschericia coli isolated from community-acquired urinary tract infections in the Gaza Strip, Palestine.
作者信息
Astal Z, Sharif F A, Abdallah Soad A, Fahd Mona I
机构信息
Khan Younis Hospital Laboratory, Islamic University of Gaza, Gaza, Palestinian Authority.
出版信息
Ann Saudi Med. 2004 Jan-Feb;24(1):55-7. doi: 10.5144/0256-4947.2004.55.
Abstract
摘要
相似文献
1
Extended spectrum beta-lactamases in Eschericia coli isolated from community-acquired urinary tract infections in the Gaza Strip, Palestine.
Ann Saudi Med. 2004 Jan-Feb;24(1):55-7. doi: 10.5144/0256-4947.2004.55.
2
Multiresistant Escherichia coli isolated from women with community-acquired urinary tract infections in the Gaza Strip.
J Chemother. 2002 Dec;14(6):637-8. doi: 10.1179/joc.2002.14.6.637.
3
Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women.
J Antimicrob Chemother. 2007 Jul;60(1):140-4. doi: 10.1093/jac/dkm144. Epub 2007 May 11.
4
Multiresistant extended-spectrum β-lactamase producing Escherichia coli in human urine samples in Portugal.
J Microbiol Immunol Infect. 2013 Oct;46(5):399-404. doi: 10.1016/j.jmii.2012.04.003. Epub 2012 Jun 21.
5
Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients.
Indian J Pharmacol. 2018 Mar-Apr;50(2):69-74. doi: 10.4103/ijp.IJP_200_17.
6
Community-acquired urinary tract infections due to extended-spectrum β -lactamase-producing organisms in United Arab Emirates.
Travel Med Infect Dis. 2018 Mar-Apr;22:46-50. doi: 10.1016/j.tmaid.2018.01.007. Epub 2018 Jan 31.
7
CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
Braz J Infect Dis. 2012 Sep-Oct;16(5):420-5. doi: 10.1016/j.bjid.2012.05.001. Epub 2012 Sep 8.
8
Community-acquired extended-spectrum beta-lactamase producers, United States.
Emerg Infect Dis. 2007 Jul;13(7):1121-3. doi: 10.3201/eid1307.070094.
9
CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey.
J Microbiol Immunol Infect. 2010 Apr;43(2):163-7. doi: 10.1016/S1684-1182(10)60026-6.
10
Clonal dissemination of highly virulent extended-spectrum beta-lactamase-producing Escherichia coli strains isolated from the urine of non-hospitalised patients in Zagreb region.
Int J Antimicrob Agents. 2008 Feb;31 Suppl 1:S19-24. doi: 10.1016/j.ijantimicag.2007.07.034. Epub 2007 Oct 23.
引用本文的文献
1
Epidemiology and clinical characteristics of patients with healthcare-acquired multidrug-resistant Gram-negative bacilli: a retrospective study from a tertiary care hospital.
Sci Rep. 2024 Feb 6;14(1):3022. doi: 10.1038/s41598-024-53596-x.
2
Prevalence and Genotypic Characterization of Extended-Spectrum Beta-Lactamases Produced by Gram Negative Bacilli at a Tertiary Care Hospital in Rural South Western Uganda.
Br Microbiol Res J. 2014 Dec;4(12):1541-1550. doi: 10.9734/BMRJ/2014/9792.
本文引用的文献
1
Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations.
Int J Antimicrob Agents. 2001 Feb;17(2):131-5. doi: 10.1016/s0924-8579(00)00325-3.
2
A 1998 survey of extended-spectrum beta-lactamases in Enterobacteriaceae in France. The French Study Group.
Antimicrob Agents Chemother. 2000 Nov;44(11):3177-9. doi: 10.1128/AAC.44.11.3177-3179.2000.
3
Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns.
J Antimicrob Chemother. 2000 Jun;45(6):895-8. doi: 10.1093/jac/45.6.895.
4
Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms, and clinical management.
Infect Dis Clin North Am. 2000 Jun;14(2):293-319. doi: 10.1016/s0891-5520(05)70249-x.
5
Occurrence of extended-spectrum betalactamases (ESBL) in Dutch hospitals.
Infection. 1999 Nov-Dec;27(6):348-54. doi: 10.1007/s150100050041.
6
Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea.
J Clin Microbiol. 1999 Jun;37(6):1758-63. doi: 10.1128/JCM.37.6.1758-1763.1999.
7
New intervention strategies for reducing antibiotic resistance.
Chest. 1999 Mar;115(3 Suppl):24S-27S. doi: 10.1378/chest.115.suppl_1.24s.
8
Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection.
Diagn Microbiol Infect Dis. 1998 Dec;32(4):317-9. doi: 10.1016/s0732-8893(98)00113-8.
9
Community acquired infections and bacterial resistance.
BMJ. 1998 Sep 5;317(7159):654-7. doi: 10.1136/bmj.317.7159.654.
10
Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.
J Antimicrob Chemother. 1996 Sep;38(3):409-24. doi: 10.1093/jac/38.3.409.
Zotero 插件